Pharmaceutical research and development pipeline - Bristol Myers Squibb

Pharmaceutical research and development pipeline  Bristol Myers Squibb

New BMS Department Head Makes Enthusiastic Return to Purdue to Take on New Leadership Role - Purd...

New BMS Department Head Makes Enthusiastic Return to Purdue to Take on New Leadership Role  Purdue University College of Veterinary Medicine

BMS builds a 'world of gratitude' to honor healthcare workers in new PSA - Fierce Pharma

BMS builds a 'world of gratitude' to honor healthcare workers in new PSA  Fierce Pharma

Advancing BMS Testing With Accurate Battery Emulation For EVs - Charged EVs

Advancing BMS Testing With Accurate Battery Emulation For EVs  Charged EVs

How BMS CAT Restored a Hotel After a 2-Alarm Fire - MarketScale

How BMS CAT Restored a Hotel After a 2-Alarm Fire  MarketScale

Mycroft Signs Speedway in Lights 5K Presented by Fleet Feet Kicks off BMS Winter Events on Novemb...

Mycroft Signs Speedway in Lights 5K Presented by Fleet Feet Kicks off BMS Winter Events on November 16  Speedway Digest

BioNTech lifts 2025 revenue guidance on BMS partnership payment - Reuters

BioNTech lifts 2025 revenue guidance on BMS partnership payment  Reuters

Bristol Myers Squibb CDTO Greg Meyers on biopharma’s AI-enabled future - McKinsey & Company

Bristol Myers Squibb CDTO Greg Meyers on biopharma’s AI-enabled future  McKinsey & Company

NXP BMS Chipset Helps Improves Battery Health Monitoring - EE Times Asia

NXP BMS Chipset Helps Improves Battery Health Monitoring  EE Times Asia

BMS' hyped schizophrenia med Cobenfy delivers so-so launch year as execs map plan for future - Fi...

BMS' hyped schizophrenia med Cobenfy delivers so-so launch year as execs map plan for future  Fierce Pharma

Independent research - Bristol Myers Squibb

Independent research  Bristol Myers Squibb

Become a business supplier - Bristol Myers Squibb

Become a business supplier  Bristol Myers Squibb

Our research in immunology - Bristol Myers Squibb

Our research in immunology  Bristol Myers Squibb

Doctorx Unscripted Bold Conversations about Patient-Driven Science - Bristol Myers Squibb

Doctorx Unscripted Bold Conversations about Patient-Driven Science  Bristol Myers Squibb

Chris Shibutani, MD - Bristol Myers Squibb

Chris Shibutani, MD  Bristol Myers Squibb

Global Inclusion & Diversity - Bristol Myers Squibb

Global Inclusion & Diversity  Bristol Myers Squibb

Transparency & reporting - Bristol Myers Squibb

Transparency & reporting  Bristol Myers Squibb

Our research in neuroscience - Bristol Myers Squibb

Our research in neuroscience  Bristol Myers Squibb

Our technologies - Bristol Myers Squibb

Our technologies  Bristol Myers Squibb

ESMO: BMS looks to 'stay ahead of the competition' with ADC's 55% response rate in early-stage tr...

ESMO: BMS looks to 'stay ahead of the competition' with ADC's 55% response rate in early-stage trial  Fierce Biotech

Worldwide locations - Bristol Myers Squibb

Worldwide locations  Bristol Myers Squibb

Sun Pharma and BMS lead 2025 ANDA litigation - Life Sciences Intellectual Property Review

Sun Pharma and BMS lead 2025 ANDA litigation  Life Sciences Intellectual Property Review

NXP Launches New EV BMS Chipset with Integrated EIS - Precedence Research

NXP Launches New EV BMS Chipset with Integrated EIS  Precedence Research

Areas of interest - Bristol Myers Squibb

Areas of interest  Bristol Myers Squibb

Research and development center Cambridge, Massachusetts - Bristol Myers Squibb

Research and development center Cambridge, Massachusetts  Bristol Myers Squibb

People and business resource groups - Bristol Myers Squibb

People and business resource groups  Bristol Myers Squibb

Science Firsthand: The renaissance of neuroscience R&D - Bristol Myers Squibb

Science Firsthand: The renaissance of neuroscience R&D  Bristol Myers Squibb

Bristol Myers reaches $239 million settlement over psoriasis, MS drugs - Reuters

Bristol Myers reaches $239 million settlement over psoriasis, MS drugs  Reuters

RayzeBio’s new hub revolutionizes cancer treatment with next-gen RPTs - Bristol Myers Squibb

RayzeBio’s new hub revolutionizes cancer treatment with next-gen RPTs  Bristol Myers Squibb

BMS’ Phase III trial of Reblozyl misses primary endpoint - Clinical Trials Arena

BMS’ Phase III trial of Reblozyl misses primary endpoint  Clinical Trials Arena

Braveheart Bio Bags $185M for Drug That Could Rival a Bristol Myers Squibb Cardio Med - MedCity News

Braveheart Bio Bags $185M for Drug That Could Rival a Bristol Myers Squibb Cardio Med  MedCity News

The Bristol Myers Squibb Foundation - Bristol Myers Squibb

The Bristol Myers Squibb Foundation  Bristol Myers Squibb

BMS Color Run! - TAPinto

BMS Color Run!  TAPinto

Clinical trials & studies - Bristol Myers Squibb

Clinical trials & studies  Bristol Myers Squibb

NXP launches EV BMS chipset with integrated electrochemical impedance spectroscopy - Charged EVs

NXP launches EV BMS chipset with integrated electrochemical impedance spectroscopy  Charged EVs

Business development leadership team - Bristol Myers Squibb

Business development leadership team  Bristol Myers Squibb

BMS plots another DTC platform, this one offering Sotyktu at 86% discount to cash-pay patients - ...

BMS plots another DTC platform, this one offering Sotyktu at 86% discount to cash-pay patients  Fierce Pharma

300+ employees from 33 nations will cycle to advance cancer research, celebrating 12 years of C2C...

300+ employees from 33 nations will cycle to advance cancer research, celebrating 12 years of C2C4C  Bristol Myers Squibb

Dispatch Bio Announces Clinical Supply and Collaboration Agreement with Bristol Myers Squibb in S...

Dispatch Bio Announces Clinical Supply and Collaboration Agreement with Bristol Myers Squibb in Solid Tumors  Business Wire

About us - Bristol Myers Squibb

About us  Bristol Myers Squibb

BMS and Takeda dive into AI data pool, joining peers in collaborative push to unfold the future -...

BMS and Takeda dive into AI data pool, joining peers in collaborative push to unfold the future  Fierce Biotech

Bristol Myers Squibb acquires cell therapy biotech Orbital for $1.5bn - European Pharmaceutical R...

Bristol Myers Squibb acquires cell therapy biotech Orbital for $1.5bn  European Pharmaceutical Review

Our impact - Bristol Myers Squibb

Our impact  Bristol Myers Squibb

Our science - Bristol Myers Squibb

Our science  Bristol Myers Squibb

Pre-approval access to investigational medicines - Bristol Myers Squibb

Pre-approval access to investigational medicines  Bristol Myers Squibb

Annual reports - Bristol Myers Squibb

Annual reports  Bristol Myers Squibb

2025 Annual Meeting of Shareholders - Bristol Myers Squibb

2025 Annual Meeting of Shareholders  Bristol Myers Squibb

Looking to the Future of Cell Therapy - Bristol Myers Squibb

Looking to the Future of Cell Therapy  Bristol Myers Squibb

Expanding access to lung cancer screening - Bristol Myers Squibb

Expanding access to lung cancer screening  Bristol Myers Squibb

BMS expands CAR-T portfolio with $1.5bn Orbital buyout - Pharmaceutical Technology

BMS expands CAR-T portfolio with $1.5bn Orbital buyout  Pharmaceutical Technology

Science Firsthand: The pathway to drug discovery - Bristol Myers Squibb

Science Firsthand: The pathway to drug discovery  Bristol Myers Squibb

Ono's BMS-partnered EP4 antagonist improves progression-free survival in phase 2 gastric cancer t...

Ono's BMS-partnered EP4 antagonist improves progression-free survival in phase 2 gastric cancer test  Fierce Biotech

Post study drug access to BMS investigational medicinal products and approved products - Bristol ...

Post study drug access to BMS investigational medicinal products and approved products  Bristol Myers Squibb

Shaping a new era in cancer research - Bristol Myers Squibb

Shaping a new era in cancer research  Bristol Myers Squibb

BMS, Bain Capital team up on autoimmune-focused newco - FirstWord Pharma

BMS, Bain Capital team up on autoimmune-focused newco  FirstWord Pharma

Why partner with us - Bristol Myers Squibb

Why partner with us  Bristol Myers Squibb

Women innovators in AI transforming patient care - Bristol Myers Squibb

Women innovators in AI transforming patient care  Bristol Myers Squibb

Biokin, having landed BMS deal, posts ph. 3 cancer win for bispecific ADC - Fierce Biotech

Biokin, having landed BMS deal, posts ph. 3 cancer win for bispecific ADC  Fierce Biotech

Bristol Myers midtrial endpoint addition secures phase 3 win in multiple myeloma - Fierce Biotech

Bristol Myers midtrial endpoint addition secures phase 3 win in multiple myeloma  Fierce Biotech

BMS sells controlling stake in historic US-China pharmaceutical joint venture - Fierce Pharma

BMS sells controlling stake in historic US-China pharmaceutical joint venture  Fierce Pharma

A&H, ‘high-friction’ casualty among lines drawing MGA buyer interest: BMS’s Curry - Insurance Ins...

A&H, ‘high-friction’ casualty among lines drawing MGA buyer interest: BMS’s Curry  Insurance Insider US

BMS to close Illinois site as part of cell therapy manufacturing consolidation - FirstWord Pharma

BMS to close Illinois site as part of cell therapy manufacturing consolidation  FirstWord Pharma

BMS inks $1.5B in vivo CAR-T buyout to pull Orbital into its sphere of influence - Fierce Biotech

BMS inks $1.5B in vivo CAR-T buyout to pull Orbital into its sphere of influence  Fierce Biotech

BMS, RayzeBio launch radiopharmaceutical manufacturing site in Indianapolis - Fierce Pharma

BMS, RayzeBio launch radiopharmaceutical manufacturing site in Indianapolis  Fierce Pharma

BMS’ Camzyos flops in Phase III non-obstructive hypertrophic cardiomyopathy trial - Clinical Tria...

BMS’ Camzyos flops in Phase III non-obstructive hypertrophic cardiomyopathy trial  Clinical Trials Arena

Alembic gets FDA nod to market BMS cancer blockbuster generic - ETPharma.com

Alembic gets FDA nod to market BMS cancer blockbuster generic  ETPharma.com

Bristol Myers, Pfizer offer Eliquis at a discount through DTC online program - Fierce Pharma

Bristol Myers, Pfizer offer Eliquis at a discount through DTC online program  Fierce Pharma

Déjà vu for Bristol Myers as it faces another anti-competition lawsuit over blockbuster Pomalyst ...

Déjà vu for Bristol Myers as it faces another anti-competition lawsuit over blockbuster Pomalyst  Fierce Pharma

Protein homeostasis 101: A Q&A with Mark Rolfe - Bristol Myers Squibb

Protein homeostasis 101: A Q&A with Mark Rolfe  Bristol Myers Squibb

Career oncologist makes Big Pharma leap to BMS—Chutes & Ladders - Fierce Biotech

Career oncologist makes Big Pharma leap to BMS—Chutes & Ladders  Fierce Biotech

BMS Makes $1.5B Cell Therapy Play With Orbital Takeover - BioSpace

BMS Makes $1.5B Cell Therapy Play With Orbital Takeover  BioSpace

Bristol Myers Squibb Commits to Veeva Vault CRM - Veeva

Bristol Myers Squibb Commits to Veeva Vault CRM  Veeva

Science Firsthand: Predicting new possibilities in drug discovery - Bristol Myers Squibb

Science Firsthand: Predicting new possibilities in drug discovery  Bristol Myers Squibb

BMS outlays $11bn to join BioNTech’s development of bispecific cancer drug - Pharmaceutical Techn...

BMS outlays $11bn to join BioNTech’s development of bispecific cancer drug  Pharmaceutical Technology

A global journey through BMS’ R&D hubs - Bristol Myers Squibb

A global journey through BMS’ R&D hubs  Bristol Myers Squibb

BMS, BioNTech Post Geographically Consistent Mid-Stage PD-L1/VEGF Data in SCLC - BioSpace

BMS, BioNTech Post Geographically Consistent Mid-Stage PD-L1/VEGF Data in SCLC  BioSpace

Introducing Workforce Planner: Your hub for managing people and projects in Kaseya BMS - Kaseya

Introducing Workforce Planner: Your hub for managing people and projects in Kaseya BMS  Kaseya

Editas Medicine Q3 net loss narrows, beats expectations - TradingView

Editas Medicine Q3 net loss narrows, beats expectations  TradingView

Bristol Myers Squibb Strengthens and Diversifies Cell Therapy Portfolio with Acquisition of Orbit...

Bristol Myers Squibb Strengthens and Diversifies Cell Therapy Portfolio with Acquisition of Orbital Therapeutics  Business Wire

In UK, Big Pharma pressure campaign rolls on as Bristol Myers plans US-level pricing for Cobenfy ...

In UK, Big Pharma pressure campaign rolls on as Bristol Myers plans US-level pricing for Cobenfy  Fierce Pharma

BMS ups guidance, but its financial prospects fail to capture investor enthusiasm - FirstWord Pharma

BMS ups guidance, but its financial prospects fail to capture investor enthusiasm  FirstWord Pharma

BMS-986365: Targeting AR Degradation and Antagonism in Metastatic Prostate Cancer - Manish Patel ...

BMS-986365: Targeting AR Degradation and Antagonism in Metastatic Prostate Cancer - Manish Patel  UroToday

BMS Deepens ALS Alliance With Insitro, Puts $2B+ On the Line - BioSpace

BMS Deepens ALS Alliance With Insitro, Puts $2B+ On the Line  BioSpace

Science Firsthand: Translating the promise of cell therapy - Bristol Myers Squibb

Science Firsthand: Translating the promise of cell therapy  Bristol Myers Squibb

Fostemsavir analog BMS-818251 has enhanced viral neutralization potency and similar escape mutati...

Fostemsavir analog BMS-818251 has enhanced viral neutralization potency and similar escape mutation profile  ASM Journals

BioNTech, BMS tout first global data for PD-L1xVEGF bispecific in small cell lung cancer, set pha...

BioNTech, BMS tout first global data for PD-L1xVEGF bispecific in small cell lung cancer, set phase 3 dose  Fierce Biotech

Bristol Myers touts commercial execution, reckons with recent clinical setbacks - Fierce Pharma

Bristol Myers touts commercial execution, reckons with recent clinical setbacks  Fierce Pharma

BMS hands 5 autoimmune drugs to new spinout backed by $300M in Bain-led funding - Fierce Biotech

BMS hands 5 autoimmune drugs to new spinout backed by $300M in Bain-led funding  Fierce Biotech

BMS, BioNTech Ink Up-to-$11B Cancer Bispecific Antibody Collaboration - Genetic Engineering and B...

BMS, BioNTech Ink Up-to-$11B Cancer Bispecific Antibody Collaboration  Genetic Engineering and Biotechnology News

BMS shuffles R&D leadership, bringing in AstraZeneca exec as new CMO - FirstWord Pharma

BMS shuffles R&D leadership, bringing in AstraZeneca exec as new CMO  FirstWord Pharma

Novo, BMS Layoffs Hit New Jersey Hard With More Than 500 Left Jobless - BioSpace

Novo, BMS Layoffs Hit New Jersey Hard With More Than 500 Left Jobless  BioSpace

Bristol Myers Squibb Appoints Cari Gallman as Executive Vice President, General Counsel and Chief...

Bristol Myers Squibb Appoints Cari Gallman as Executive Vice President, General Counsel and Chief Policy Officer  Bristol Myers Squibb

Immunology Drug Sotyktu Will Kick Off Bristol Myers Squibb’s New Direct-to-Patient Platform - Med...

Immunology Drug Sotyktu Will Kick Off Bristol Myers Squibb’s New Direct-to-Patient Platform  MedCity News

In New Jersey, Novo Nordisk cuts 263 workers while BMS slashes 282 roles - Fierce Pharma

In New Jersey, Novo Nordisk cuts 263 workers while BMS slashes 282 roles  Fierce Pharma

BMS names AstraZeneca's Cristian Massacesi as new chief medical officer - Fierce Biotech

BMS names AstraZeneca's Cristian Massacesi as new chief medical officer  Fierce Biotech

BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal - Fierce Biotech

BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal  Fierce Biotech

Bristol Myers braves failed Reblozyl phase 3, plans FDA talks for potential anemia expansion - Fi...

Bristol Myers braves failed Reblozyl phase 3, plans FDA talks for potential anemia expansion  Fierce Pharma

Bristol Myers Squibb CEO: Pharmaceutical innovation requires bold yet predictable U.S. policy - s...

Bristol Myers Squibb CEO: Pharmaceutical innovation requires bold yet predictable U.S. policy  statnews.com

BMS acquires Orbital Therapeutics in $1.5bn deal - PMLiVE

BMS acquires Orbital Therapeutics in $1.5bn deal  PMLiVE

BioNTech lifts 2025 revenue guidance on BMS partnership payment - Yahoo

BioNTech lifts 2025 revenue guidance on BMS partnership payment  Yahoo